These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7022962)

  • 21. HLA-A, B matching of pretransplant blood transfusion is associated with poor graft survival.
    Albert ED; Scholz S; Meixner U; Land W
    Transplant Proc; 1981 Mar; 13(1 Pt 1):175-7. PubMed ID: 7022817
    [No Abstract]   [Full Text] [Related]  

  • 22. HLA-DR matching in cadaveric renal transplantation.
    N Engl J Med; 1981 Feb; 304(8):488-9. PubMed ID: 7005684
    [No Abstract]   [Full Text] [Related]  

  • 23. Importance of HLA-A, -B and -DR matching in presensitized kidney transplant recipients.
    Busson M; Hors J; Prevost P; Raffoux C; Betuel H; Bignon JD; Tongio MM; Seignalet J; Calot M; Lepetit JC
    Clin Transpl; 1988; ():199-202. PubMed ID: 3154473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal transplantation in Australia and New Zealand, 1963-1982: report from the ANZ Data Registry.
    Disney A
    Transplant Proc; 1984 Aug; 16(4):973-8. PubMed ID: 6380061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

  • 26. Immediate rejection of a HLA-A, B compatible, HLA-DR incompatible kidney with a positive donor-recipient B-cell crossmatch.
    Berg B; Möller E
    Scand J Urol Nephrol Suppl; 1980; 54():36. PubMed ID: 7013039
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current status of human renal allograft and experimental prolongation of renal graft survival].
    Hirano T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):389-92. PubMed ID: 6386637
    [No Abstract]   [Full Text] [Related]  

  • 28. HLA matching effect: better survival rates and graft quality.
    Cho YW; Cecka JM; Terasaki PI
    Clin Transpl; 1994; ():435-49. PubMed ID: 7547574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of HLA-A, B, and DR matching on graft survival in primary cadaveric renal transplantation in Belfast.
    Middleton D; Gillespie EL; Doherty CC; Douglas JF; McGeown MG
    Transplantation; 1985 Jun; 39(6):608-10. PubMed ID: 3890289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pitfalls in tissue typing for kidney transplantation.
    Betuel H; Gebuhrer L; Traeger J
    Kidney Int Suppl; 1985 Dec; 17():S170-4. PubMed ID: 2419625
    [No Abstract]   [Full Text] [Related]  

  • 32. Importance of HLA-DR matching in polytransfused cadaveric kidney transplant recipients. A prospective one-center study.
    Vanrenterghem Y; Vandeputte I; Lerut T; Roels L; Gruwez J; Michielsen P
    Transplantation; 1983 Oct; 36(4):384-7. PubMed ID: 6353705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of tissue typing in cadaveric kidney transplantation (pros).
    Sirchia G
    Contrib Nephrol; 1982; (34):101-10. PubMed ID: 6756776
    [No Abstract]   [Full Text] [Related]  

  • 34. International study of histocompatibility in renal transplantation.
    Opelz G; Terasaki PI
    Transplantation; 1982 Jan; 33(1):87-95. PubMed ID: 7039026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful DR-incompatible cadaver kidney transplantation. Combined effect of HLA A and B matching and blood transfusion.
    Schulak JA; Goeken NE; Nghiem DD; Corry RJ
    Transplantation; 1984 Dec; 38(6):649-53. PubMed ID: 6390828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
    Martin S; Connolly J; Jos V
    Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
    [No Abstract]   [Full Text] [Related]  

  • 37. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of blood transfusions and HLA matching on national kidney transplant programs: the first Swedish-Norwegian Study of cyclosporine.
    Albrechtsen D; Flatmark A; Brynger H; Frödin L; Gäbel H; Groth CG; Lundgren G; Maurer W
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):257-60. PubMed ID: 3291252
    [No Abstract]   [Full Text] [Related]  

  • 39. Human leukocyte antigen matching in renal transplantation: review and current status.
    Zmijewski CM
    J Surg Res; 1985 Jan; 38(1):66-87. PubMed ID: 3917516
    [No Abstract]   [Full Text] [Related]  

  • 40. HLA and renal transplantation: yet another approach.
    MacLeod AM; Mason RJ; Catto GR
    J Med Genet; 1981 Dec; 18(6):461-3. PubMed ID: 7038116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.